References
- Donowitz M. Arachidonic acid metabolites and their role in inflammatory bowel disease. An update requiring addition of a pathway. Gastroenterology 1985; 88: 5800–5811
- Rampton D S, Hawkey CJ. Prostaglandins and ulcerative colitis. Gut 1985; 25: 1399–1413
- Sharon P, et al. Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine. Gastroenterology 1978; 75: 638–640
- Gould S R, et al. Studies of prostaglandins and sul-phasalazine in ulcerative colitis. Prostaglandins Med 1981; 6: 165–182
- Ford-Hutchinson A W, et al. Leukotriene B a potent chemotactic and aggregating substance released from polymorphonuclear leukocytes. Nature 1984; 266: 264–265
- Musch M W, et al. Bradykinin stimulated electrolyte secretion in rabbit and guinea pig intestine: Involvement of arachidonic acid metabolites. J Clin Invest 1983; 71: 1073–1083
- Sharon P, Stenson WF. Enhanced synthesis of leukotriene B4by colonic mucosa in inflammatory bowel disease. Gastroenterology 1984; 86: 453–460
- Boughton-Smith N K, Hawkey C J, Whittle B, JR. Biosynthesis of lipoxygenase and cyclooxygenase products from14C-arachidonic acid by human colonic mucosa. Gut 1983; 24: 1176–1182
- Peskar B M, et al. Enhanced formation of sulfido-peptide-leukotrienes in ulcerative colitis and Crohn's disease: inhibition by sulfasalazine and 5-aminosalicylic acid. Agents Actions 1986; 18: 381–383
- Lauritsen K, et al. Effects of topical 5-aminosalicylic acid and prednisolone on prostaglandin E2and leukotriene B4levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis. Gastroenterology 1986; 88: 837–846
- Sharon P, Stenson WF. Metabolism of arachidonic acid in acetic acid colitis in rats: similarity to human inflammatory bowel disease. Gastroenterology 1985; 88: 55–63
- Clark J G, Kuhn C. Bleomycin-induced pulmonary fibrosis in hamsters: Effect of neutrophil depletion on lung collagen synthesis. Am Rev Respir Dis 1982; 126: 737–739
- Gallin J I, Clark R A, Kaplan AP. Granulocyte chemotaxis, an improved in vitro assay employing51Cr-labeled granulocytes. J Immunol 1973; 110: 233–240
- Lobos E A, Sharon P, Stenson WF. Chemotactic activity in inflammatory bowel disease: role of leukotriene B4. Dig Dis Sci 1987; 32: 1380–1388
- Das K M, Dubin R. Clinical pharmacokinetics of sulfasalazine. Clin Pharmacokinet 1976; 1: 406–425
- Stenson W F, Lobos E. Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils. J Clin Invest 1982; 69: 494–497